ZEISS Looks Back on Overall Good Fiscal Year 2019/20

Revenue reaches 6.3 billion euros (-2% vs. prior year) - EBIT at 922 million euros (-141 million euros vs. prior year)


-- Stability thanks to ZEISS portfolio and global positioning - even during
COVID-19 pandemic
-- ZEISS segments impacted differently by COVID-19 pandemic
-- Strong growth over prior year in Semiconductor Manufacturing Technology
segment due to EUV technology
-- Significant investments in research and development pay off
-- Clear recovery trend in all ZEISS segments
OBERKOCHEN, Germany, Dec. 17, 2020 /PRNewswire/ -- Overall, the ZEISS Group had a good fiscal year 2019/20 (end of reporting period: 30 September 2020): revenue totaled 6.297 billion euros (prior year: 6.428 billion euros). With a slight decline of 2% due to the COVID-19 pandemic, revenue almost reached last year's level. Around 90% of revenue was generated in markets outside Germany. Earnings before interest and taxes (EBIT) were also relatively high, reaching 922 million euros (prior year: 1.063 billion euros). The EBIT margin was 15%. Incoming orders increased to 6.814 billion euros (prior year: 6.575 billion euros).

https://mma.prnewswire.com/media/1387366/dr_karl_lamprecht.jpg [https://mma.prnewswire.com/media/1387366/dr_karl_lamprecht.jpg]

"On the whole, we were able to achieve a good business result for the ZEISS Group, thanks also to our broad portfolio and global positioning. We consider this an exceptional achievement by our employees - in unusual times," says Dr. Karl Lamprecht, President and CEO of ZEISS. "Our global crisis management, supported by resilience measures that had already been developed, helped us tackle the challenges of the COVID-19 pandemic as well as possible."






Revenue (in million euros)



2019/20 2018/19

Change

(adjusted for currency
effects)



Semiconductor
Manufacturing
Technology 1,833 1,634
+12% (+12%)

---

Industrial
Quality
&
Research 1,640 1,742
-6% (-5%)

---

Medical
Technology* 1,647 1,760
-6% (-6%)

---

Consumer
Markets 1,099 1,211
-9% (-8%)

---


* Not identical to Carl Zeiss Meditec Group

Contact:
Jörg Nitschke
Phone: +49 7364 20-3242
joerg.nitschke@zeiss.com [mailto:joerg.nitschke@zeiss.com]
https://www.zeiss.com/ [https://www.zeiss.com/]

Photo: https://mma.prnewswire.com/media/1387366/dr_karl_lamprecht.jpg [https://mma.prnewswire.com/media/1387366/dr_karl_lamprecht.jpg]

PR Newswire

Dit persbericht is via ANP Pers Support naar internationale (vak en online) media gestuurd. Heb je nieuws voor buitenlandse journalisten? Bekijk dan onze mogelijkheden of neem contact met ons op.

Verstuur nu éénmalig een persbericht

Verstuur persberichten en beeldmateriaal naar redacties in binnen- en buitenland. Via het ANP-net, het internationale medianetwerk van PR Newswire of met een perslijst op maat.

Direct persbericht versturen
070 - 41 41 234